DRDGOLD Limited (DRD)
Johannesburg Exchange · South Africa · prices in ZAC · close of 23 Oct 2026
Key indicators
| Last close | ZAC 3,998.00 |
|---|---|
| 52-week range | 3,232.00 – 6,500.00 |
| Return, 1 month / 3 months | −4.7% / +15.9% |
| Return, 1 year / 3 years | −10.2% / +128.6% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 52.9% |
| Worst drawdown (1 year) | -47.9% |
| Average daily value traded | 6,278.93M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
DRDGOLD Limited is a South African gold producer that recovers gold from the retreatment of surface tailings and slimes dumps left by earlier mining. Its operations sit in the Witwatersrand region, where it processes old mine residue to extract remaining metal, and it also runs related tailings and environmental rehabilitation work. The company is based in South Africa and serves the gold market through the recovery and refining of metal from these surface sources.
On this site DRDGOLD Limited appears as a stock on the Johannesburg Exchange (South Africa), code DRD, with prices in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
DRDGOLD Limited (DRD) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 3,998.00 on 23 October 2026.
Its price-based Market X-Ray is 39 out of 100 (a weak price profile), ranking 165 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.2% and over the last three months it rose 15.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 23 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.4% | ||
| From 52-week high | -35.9% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 15.9% | ||
| 6-month return | -16.3% | ||
| 12-month return, skipping the last month | -5.8% | ||
| Stability (higher is calmer) | 24 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 52.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -47.9% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 6,278.93M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −4.8% |
|---|---|
| 1 month | −4.7% |
| 3 months | +15.9% |
| 6 months | −16.3% |
| 1 year | −10.2% |
| 3 years | +128.6% |
| 5 years | +208.5% |
Signals
| 50-day / 200-day average | 4,284.92 / 4,563.25 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 154.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Mar 2023 | ZAC 20.0000 |
| 21 Sep 2022 | ZAC 40.0000 |
| 9 Mar 2022 | ZAC 20.0000 |
| 21 Sep 2021 | ZAC 40.0000 |
| 3 Mar 2021 | ZAC 40.0000 |
| 22 Sep 2020 | ZAC 35.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.